For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Power Solutions International, Inc. (PSIX) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Watch · Gem Score -6 (−100…+100 Quality+Value blend) · Quality 12 · Value -21 · Sentiment -60 (timing only, not weighted) · Composite fair value $24.18 vs $27.61 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Power Solutions International, Inc.
PSIX NASDAQPower Solutions International, Inc. is a manufacturing company specializing in the design, engineering, and production of advanced, emission-certified engines and power systems. It delivers integrated turnkey power solutions to original equipment manufacturers (OEMs) and end-user customers across power systems, industrial, and transportation markets. The company's fuel-agnostic engines operate on natural gas, propane, gasoline, diesel, and biofuels, ensuring compliance with stringent environmental regulations like those from the U.S. Environmental Protection Agency. In the power systems segment, it provides complete solutions for stationary and mobile power generation, including standby, prime, demand response, microgrids, data centers, and co-generation applications. For industrial uses, offerings include engine and battery powertrains for forklifts, agricultural machinery, turf equipment, aerial lifts, irrigation pumps, airport ground support, and construction gear. In transportation, it supplies purpose-built powertrains for medium-duty trucks, buses, work trucks, terminal tractors, port equipment, and military vehicles. With in-house prototyping, testing, and customization capabilities, Power Solutions International, Inc. supports diverse global applications in off-highway and on-road sectors. Founded with headquarters in Wood Dale, Illinois, it stands as a key supplier of clean, high-performance power technologies.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.94
Total Equity: $178.61M
Shares: 23,066,000
Total Debt: $38,000
Cash: $41.25M
EBITDA: N/A
Total Debt: $38,000
Cash: $41.25M
Revenue: $722.41M
Revenue: $722.41M
Revenue: $722.41M
Total Equity: $178.61M
Tax Rate: -10.3%
Equity: $178.61M
Total Debt: $38,000
Cash: $41.25M
Current Liabilities: $92.28M
Long-Term Debt: $10,000
Total Debt: $38,000
Total Equity: $178.61M
Shares: 23,066,000
Shares: 23,066,000
CapEx: $0.00
Shares: 23,066,000
Stock Price: $27.61
Net Income: $113.99M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 2, 2026 1:55pm (21d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $456.3M | $481.3M | $459.0M | $476.0M | $722.4M |
| Cost of Revenue | $415.0M | $392.8M | $353.1M | $335.4M | $537.5M |
| Gross Profit | $41.3M | $88.6M | $105.9M | $140.5M | $184.9M |
| Operating Expenses | $82.8M | $64.0M | $61.6M | $58.9M | $75.2M |
| Operating Income | -$41.6M | $24.6M | $44.3M | $81.6M | $109.7M |
| Net Income | -$48.5M | $11.3M | $26.3M | $69.3M | $114.0M |
| EBITDA | — | — | — | — | — |
| EPS | $-2.12 | $0.49 | $1.15 | $3.01 | $4.95 |
| EPS (Diluted) | $-2.12 | $0.49 | $1.15 | $3.01 | $4.94 |
Balance Sheet (Annual)
Last updated: Aug 2, 2026 1:24pm (21d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $6.3M | $24.3M | $22.8M | $55.3M | $41.3M |
| Total Current Assets | $230.2M | $255.3M | $205.4M | $254.3M | $290.9M |
| Total Assets | $300.5M | $319.9M | $284.3M | $328.2M | $424.7M |
| Current Liabilities | $283.3M | $319.3M | $248.3M | $227.6M | $92.3M |
| Long-Term Debt | $25.6M | $5.0M | $90,000 | $38,000 | $10,000 |
| Total Liabilities | $342.6M | $350.3M | $288.2M | $262.9M | $246.1M |
| Total Equity | -$42.0M | -$30.4M | -$3.9M | $65.3M | $178.6M |
| Retained Earnings | -$198.4M | -$187.1M | -$160.8M | -$91.5M | $22.5M |
Cash Flow (Annual)
Last updated: Aug 2, 2026 1:55pm (21d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$61.5M | -$8.8M | $70.5M | $62.4M | $24.1M |
| Capital Expenditure | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | — | $-256,000 | $-215,000 | $-204,000 | $-482,000 |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — |
| Net Change in Cash | -$14.5M | $18.2M | -$1.3M | $31.9M | -$13.5M |
Growth Trends (YoY %)
Last updated: Aug 2, 2026 1:55pm (21d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +5.5% | -4.6% | +3.7% | +51.8% |
| Gross Profit Growth | +114.6% | +19.5% | +32.8% | +31.6% |
| Operating Income Growth | +159.2% | +80.0% | +84.4% | +34.4% |
| Net Income Growth | +123.3% | +133.4% | +163.4% | +64.5% |
| EBITDA Growth | — | — | — | — |
Deep Analysis
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-19 10:58Even the bull case prices 31% below today — the ratio here measures the model-vs-market gap, not payoff odds. Another quarter like the worst recent one costs 72%.
| Case | Growth | Margin | Fair value | vs price ($27.61) |
|---|---|---|---|---|
| Bull — recovery | +3% | 11.5% | $18.99 | -31% |
| Base — stabilizes | +2% | 10.0% | $16.51 | -40% |
| Bear — keeps slipping | +1% | 8.5% | $14.16 | -49% |
| Stress — last quarter repeats | -21% | 9.3% | $7.65 | -72% |
Narrative Economics
market-narrative step).
Claude Reading
The raw numbers tell a very specific story that the models are dancing around: PSIX had a monster 2025 (revenue $722M vs $476M in 2024, +52%; NI $114M vs $69M) but the quarterly cadence shows a peak in Q2/Q3 2025 ($191.9M/$203.8M) followed by sequential declines to $128.6M in Q1 2026 — a 37% drop from peak in three quarters. Net margin compressed from 26.7% in Q2'25 to 5.7% in Q1'26, a five-fold collapse. That Q2'25 26.7% margin is anomalous for a specialty engine OEM (peers like Cummins run 10-13%); it almost certainly contained a discrete tax benefit or one-time item — NI of $51M on $192M revenue is not a repeatable industrial margin. The trailing $114M NI on which the 5.6x P/E rests is therefore contaminated by non-recurring gains. Normalize to a run-rate ~8-10% margin on ~$550-600M revenue and you get $45-60M NI, or roughly 11-14x on $640M cap — not cheap, not expensive.
The prior models are all over the map and largely wrong in different directions. The Valuation Synthesis $130 fair value (a 371% upside) is absurd — it's extrapolating peak margins in a DCF and should be discarded. The Pre-Flight "deep value" framing was defensible six months ago but is stale given the Q1'26 print showing revenue and margin both rolling over hard. Market Forces and Thesis Evaluation are closer to reality — "overearning in a temporary boom" and "priced for a cyclical peak it just delivered" both match what the quarterlies actually show. The mature_earner archetype is wrong; PSIX went from a -$48M loss in 2021 to +$114M in 2025 — this is a cyclical/turnaround, not a stable compounder. Balance sheet is genuinely pristine ($38K debt, $41M cash, 3.2x current ratio, 88% ROIC), which is the one uncontestable bull point and explains why the stock hasn't collapsed further despite the deceleration.
A careful contrarian would push back on the bear consensus in two ways. First, data center backup power demand (stationary natural gas gensets, PSIX's core wheelhouse) is genuinely structural — hyperscaler capex on backup power is a 3-5 year tailwind, not a 2025 one-off, and PSIX's Weichai parent relationship gives it supply advantages. Second, the insider "unusual selling" flag is thin: 8,238 shares sold in September 2025 against multiple award grants is noise, not a signal of executive panic. But the Q1'26 revenue collapse to $128.6M is hard to explain away as seasonality — Q1'25 was $135.4M, so this is a -5% YoY print after a +52% annual, meaning the trajectory has already inflected. Free cash flow CAGR of -41.5% against earnings CAGR of +108% is the tell: reported earnings are diverging from cash, which usually means working capital build or accrual-heavy revenue recognition. Operating CF of $24M on $114M NI in 2025 is a 21% conversion ratio — abysmal and consistent with the "overearning" thesis.
I dissent hard from the Synthesis $130 fair value and partially agree with Market Forces/Thesis Eval. My read: normalized earnings power is $45-55M, deserving 10-12x for a cyclical industrial with customer concentration and no dividend, giving fair value $7-11 per share on trough assumptions or $18-22 on mid-cycle. Current $27.61 embeds a mid-cycle-plus scenario. The optical 5.6x P/E is a value trap built on a non-repeatable 2025. That said, the debt-free balance sheet and data center exposure prevent this from being a short — this is a "avoid, revisit after two more quarterly prints" name. If Q2'26 shows revenue re-accelerating above $160M with margins stabilizing above 10%, the structural thesis gets a real hearing. If Q2'26 prints another sub-$140M quarter, this goes to $15. The asymmetry currently favors patience over either direction.
GPT Reading
PSIX screens optically cheap, but the raw numbers say “normalize me,” not “4x your money.” The core fact pattern is a business that went from $456 million of revenue and a $48.5 million loss in 2021 to $722 million of revenue and $114 million of net income in 2025, while essentially eliminating balance-sheet risk: just $38K of debt against $41.3 million of cash. That is real operational improvement, not financial engineering. But the shape of the quarterly data matters more than the annual snapshot. Revenue rose from $110.6 million in 2Q24 to $203.8 million in 3Q25, then fell to $191.2 million in 4Q25 and $128.6 million in 1Q26. Net margin followed the same arc, from a remarkable 26.7% in 2Q25 to 13.5%, then 8.4%, then 5.7%. On a trailing four-quarter basis through 1Q26, revenue is still a strong $715.5 million, basically flat with full-year 2025, but earnings power is clearly rolling over.
That rollover is why the 5.6x P/E is less compelling than it looks. At today’s $0.64 billion market cap, investors are paying about 0.9x sales for a company whose 2025 net margin was 15.8%, but whose latest quarter printed just 5.7%. If 2025 was the sustainable base, the stock would be absurdly cheap. If instead normalized earnings settle closer to a high-single-digit net margin on roughly $650-725 million of sales, then net income is more like $45-65 million, not $114 million. On that base, the stock is trading more like 10-14x earnings, which is not expensive, but it is no longer a glaring mispricing for a small industrial business with volatile demand and uncertain mix. The cash flow data reinforces the caution: $114 million of net income in 2025 only produced $24.1 million of operating cash flow. Without capex data, I cannot underwrite the earnings quality aggressively. That disconnect does not prove trouble, but it absolutely weakens the “deep value” case.
What stands out most is that the models are talking past the actual cadence. A $127 fair value implies either that 2025 margins are durable or that growth is about to reaccelerate; the reported quarter says neither. Gross margin for 2025 was 25.6% and operating margin 15.2%, both excellent relative to the company’s own history, yet recent quarterly net margins have compressed for three straight periods. That could be product mix, absorption, pricing, or temporary inefficiency, but until proven otherwise the burden of proof is on the bull. The “mature earner” label is also too generous. Mature earners do not usually show this kind of earnings whipsaw after a breakout year, nor do they post ROE of 63.8% and ROIC of 88.1% without some element of unusual profitability or a thin equity base magnifying the ratios. This is a turnaround/cyclical special situation wearing a value multiple, not a stable compounder the market forgot to notice.
The best argument against my caution is straightforward: even after the ugly-looking 1Q26, PSIX still earned $102 million over the last four quarters, which puts the current market cap at roughly 6.3x trailing earnings, with a net cash balance sheet and a current ratio above 3.0. Revenue in 1Q26 was down sequentially, but versus 1Q25 it was still down only modestly from $135.4 million to $128.6 million, and the company remained profitable. On a multi-year view, margins have not merely bounced from trough levels; they have structurally reset higher, with annual operating income rising from -$41.6 million in 2021 to $109.7 million in 2025. If management has truly fixed manufacturing, sourcing, and pricing discipline, then what looks like normalization could instead be normal quarter-to-quarter lumpiness after an unusually strong mid-2025. In that case, today’s multiple is too low for a debt-free industrial earning even $75-90 million sustainably.
What would flip me bullish is not another backward-looking annual P/E argument; it is evidence that the recent compression has bottomed. I would want to see at least two things in upcoming quarters: revenue stabilize back above roughly $160-170 million and net margin recover into at least the 9-12% range, which would support annualized earnings power materially above $60 million. I would also want operating cash flow to track much closer to net income over a full year, because $24.1 million of OCF against $114 million of earnings is too weak for me to capitalize at a premium. If instead the next couple of quarters stay around 5-7% net margins with revenues below the 2025 run-rate, then the stock is already about where it should be.
Grok Reading
The numbers tell a story of a genuine operational turnaround that peaked hard in 2025 and is already giving it back. Revenue leapt from $476M in 2024 to $722M in 2025 (+52%), net income from $69M to $114M, and operating margin expanded to 15.2% with ROE at an eye-watering 64%. That is not incremental improvement; it is a step-change. Yet the very next quarter—Q1 2026—revenue fell to $128.6M (down 5% YoY from $135.4M and down 33% sequentially from $191M), while net margin collapsed to 5.7% from 14.1% a year earlier and from the absurd 26.7% printed in Q2 2025. The trailing 5.6x P/E and 0.88x P/S therefore capitalize a year that already looks anomalous. Worse, operating cash flow of only $24.1M against $114M of net income in 2025 is a flashing red earnings-quality signal; the company converted barely 21 cents of every reported earnings dollar into cash even in its banner year. With essentially zero debt ($38k) and $41M cash against a $640M market cap, the balance sheet is pristine, but that does not make the income statement durable.
What stands out most is the speed of the margin mean-reversion already underway. Gross margin for the full year sat at 25.6%, yet the quarterly NI margin sequence—14.1%, 26.7%, 13.5%, 8.4%, 5.7%—shows the peak was a single-quarter event, not a new plateau. Secondary signals correctly flag decelerating revenue confidence and unusual insider selling. The rule-based “mature earner” label and the $127–130 composite fair-value outputs are simply wrong; they appear to be capitalizing peak 2025 earnings at mid-cycle multiples as if the 52% revenue spike and 65% earnings jump are the new run-rate. They are not. Normalized earnings power looks closer to the $50–70M zone (roughly 2024 levels or a bit better), which at the current enterprise value of roughly $600M still implies a single-digit to low-teens earnings multiple—cheap, but not 5x cheap once you stop treating 2025 as permanent.
The strongest case against this cautious read is straightforward: even if 2025 was a cyclical high, cutting those earnings in half still leaves the stock at roughly 11x, debt-free, with a current ratio above 3 and a multi-year history of rising gross margins from 9% in 2021 to 26% in 2025. The data-center backup and fuel-agnostic engine exposure is real industrial demand, not pure narrative, and the clean balance sheet removes any near-term solvency discount. A smart bull would also note that Q1 has historically been the seasonal trough (2025 Q1 was the weakest quarter of that year), so annualizing $129M and 5.7% margins is too punitive. I weigh this less heavily because the cash conversion failure is structural until proven otherwise, and the YoY margin compression in Q1 2026 is too severe to dismiss as seasonality alone; the market’s 5.6x trailing multiple already embeds the correct skepticism that 2025 over-earned.
I would flip to a high-conviction undervalued stance if Q2 2026 revenue rebounds above $180M with net margins back above 12% and, critically, if trailing twelve-month operating cash flow begins to track at least 60–70% of net income. Conversely, another quarter of sub-8% margins or further revenue contraction below the $130M quarterly run-rate would confirm the bear case that 2025 was a one-time spike and push the stock toward fairly valued or worse at this price.
Big-3 Panel — where each AI stands
Claude — Second Response · fairly valued changed direction
VERDICT: Fairly valued tilted rich at $27.61; normalized fair value $20-26 on $55-65M earnings power at 11-12x, wait for Q2'26 cash conversion and margin print before committing
The convergence is real but I want to name what actually moved me versus what didn't. GPT's framing of "burden of proof is on the bull" and the specific math — $102M trailing NI, 6.3x, but $24M OCF against $114M NI — is the same case I made, just with a slightly more generous stabilization scenario ($60M+ run-rate flips them bullish, vs. my $18-22 mid-cycle anchor). Grok's read is closer to a soft-bull tilt: "modestly undervalued at $27.61 on $50-70M normalized." That's the argument I need to engage with seriously, because $50-70M normalized at 10-12x actually gets you to $23-32 — overlapping my $18-22 range on the low end and exceeding current price on the high end.
What did NOT move me: the seasonality defense of Q1'26. Grok gestures at it then correctly discounts it — Q1'25 was $135.4M and Q1'26 printed $128.6M, so YoY is already negative even before mix/margin. The seasonal-trough argument would need Q1'26 to be down less than Q1'25 was versus its trailing quarters, and it isn't. What DID sharpen my thinking: GPT's point that operating margin structurally reset from -$42M in 2021 to +$110M in 2025 is not nothing. Even if Q2'25's 26.7% NI margin was anomalous, the 2024 baseline ($476M revenue, ~14.5% NI margin) is itself a legitimate reset from the 2021-2022 disaster. That means my "trough $7-11" scenario probably underweights the structural gross margin gains (9% → 26%), which look durable across multiple quarters, not just the peak.
Net: I'm narrowing my range but holding direction. Fair value $20-26 on $55-65M normalized earnings at 11-12x, meaning $27.61 is at the top of fair — not a short, not a buy, and the Synthesis $127-130 remains indefensible. The 21% OCF/NI conversion is the single most important unresolved fact and neither colleague can explain it away either. I move from "overvalued" to "fairly valued, tilted rich" because the structural margin reset deserves more weight than I gave it, but I refuse to call this undervalued while cash conversion is broken and revenue has inflected.
GPT — Second Response · fairly valued held
VERDICT: Fairly valued in the mid-to-high $20s; attractive below ~$20, and I’d need evidence of >$60M sustainable earnings with materially better cash conversion to underwrite upside above ~$30.
Claude’s note strengthened my downside framing on one important point: I underweighted just how much the trailing P/E is being “contaminated” by the Q2’25 profit spike. I agree the 26.7% net margin on $192M of revenue is not a sane base rate for a small industrial OEM, and his mid-cycle math of roughly $45–60M normalized earnings is close to my own $45–65M range. What did not move me is the leap from that normalization to a clearly overvalued call at today’s price. With a net-cash balance sheet, no leverage risk, and even a conservative earnings base implying something like low-teens P/E, I still don’t see obvious overvaluation unless you assume both lower revenue ($550–600M) and structurally weak margins at the same time. That is possible, but not yet proven.
Grok’s read is closer to where I land after reconsideration: modest cheapness on normalized earnings is arguable, but the burden of proof remains on durability and cash conversion. The cash point remains the biggest obstacle to a bullish revision. $24M of operating cash flow against $114M of net income in 2025 is too poor to dismiss, and both colleagues were right to press that harder. Likewise, the quarterly margin sequence clearly says 2025 was a peak year, not a stable plateau. But I still resist calling it a trap at $27.61 because even if earnings normalize to, say, $50–70M, the stock is not expensive for a debt-free niche manufacturer with genuine data-center backup power exposure. That leaves me essentially where I started, but with slightly greater skepticism toward the headline cheapness and slightly less willingness to describe the shares as attractive absent confirmation from Q2/Q3. I hold: fair value remains in the 20s, with interest only on either a much lower price or evidence margins rebase higher with better cash conversion.
Grok — Second Response · fairly valued changed direction
VERDICT: Fairly valued at $27.61 on ~$50M normalized earnings; no edge until Q2’26 confirms stabilization above $60M run-rate
The colleagues’ normalization math lands in essentially the same $45-65M zone I used, yet both correctly tighten the multiple that zone deserves. Claude’s peer benchmark (Cummins-type industrials at 10-13% net) and the five-fold margin collapse from the 26.7% Q2’25 spike make plain that 2025’s $114M is contaminated; once you discard the outlier quarter, mid-cycle earnings power sits closer to $50M than $70M. At that level a 10-12x multiple on a debt-free but still-volatile specialty OEM with 21% cash conversion is $18-26, not a discount. GPT’s TTM observation ($102M still on the books) is fair, but the sequential revenue and margin path already shows that figure is decaying in real time, so capitalizing it at 6x is optimistic rather than conservative.
What failed to move me is any claim that the data-center tailwind or pristine balance sheet suddenly restores 2025 run-rate durability; both colleagues acknowledge those positives yet still land at fair-to-overvalued, and the numbers support them. Insider selling remains noise, seasonality alone cannot explain a –5% YoY Q1 after a +52% year, and OCF/NI divergence is structural until proven otherwise. I therefore drop the “modestly undervalued” label: $27.61 already embeds a mid-cycle-plus scenario. I will re-rate higher only on the exact evidence I originally flagged—Q2 revenue >$160-180M, margins >10%, and cash conversion rising toward 60%+.
Advanced Analysis Forensic deep-dive · separate lenses
PSIX has executed a genuine operational transformation: revenue jumped from $456M in 2021 to $722M in 2025 (58% cumulative), gross margin expanded from 9% to a peak of 29.5% in 2024 (25.6% in 2025), and operating margin swung from -9.1% to 15-17%. Net income moved from a $48.5M loss to $114M profit, and FCF has been positive three years running ($70.5M, $62.4M, $24.1M). Diluted share count has been essentially flat at ~23M (0.2% CAGR) with SBC only 0.1% of revenue — per-share value is being protected. Balance sheet is in reasonable shape with $41.3M net cash and Altman Z of 4.74 (safe zone).
Verify before trusting this (6)
- 10-K disclosure of Weichai related-party transactions (supply, distribution, financing) and revenue concentration
- Working-capital movements driving the 2025 FCF drop (AR/inventory build vs. revenue growth of 52%)
- Customer concentration in data-center/backup-power end market driving the 2025 revenue surge
- Whether the recent margin level (25-29% GM) reflects mix shift that is durable or a cyclical spike
- Nature and terms of Weichai's Rule 144 sales and any registration/lockup arrangements
- Any material tax benefits or one-time items inflating 2025 net income relative to operating performance
The e2e composite fair value of $127 and signal-adjusted $130 imply ~370% upside, but that number is driven almost entirely by an anchored-PE of $230 applied to a 2025 net income of $114M whose OCF/NI is under 1x and whose FCF was only $24M. Capitalizing a low-quality earnings spike at a normal multiple is exactly how DCF/PE methods run away. I trust the EPV floor of $24.96 far more — and the stock at $27.61 is trading right on top of it. That means the market is already giving PSIX credit for the turnaround; there is no gaping discount here.
Verify before trusting this (4)
- Sustainability of 2025 margin — is the NI/FCF gap a working-capital timing issue or accrual quality?
- Weichai's stake disposition plan and any registered secondary sizing
- Customer concentration disclosure and backlog mix (data-center/genset vs legacy on-highway)
- Normalized tax rate assumption behind the $114M figure
PSIX isn't riding any story right now. The narrative is fallen-angel with minimal intensity and fragile durability, cult coefficient low - meaning there is no believer base to defend the stock on down days and no momentum crowd chasing it on up days. The bull case (fuel-agnostic engines, energy-transition supplier) is intellectually available but the tape isn't paying for it; the bear case (diesel's long tail vs. EV cannibalization, thin moat, customer concentration) is the frame the market has adopted. That is a classic setup where sentiment pressure is quietly negative even when fundamentals aren't the issue. Layered on top: a 39% single-day collapse on May 12 after a Q1 miss plus new lawsuits, and a 17.7% drop the prior day. That kind of print scars sentiment for a full quarter - it becomes the reference event every analyst note and screen flags. The macro tape is only mildly constructive (neutral, +22, VIX 16), but with beta 2 this name amplifies whatever the market does; a small S&P wobble becomes a real drawdown here, and the recent 1.6% pullback from highs already tells you risk appetite for high-beta small-cap industrials is not the priority bid. Net: the story isn't working, the last catalyst was a disaster, and the tape offers no cover. Momentum is technically strong on longer windows but that is backward-looking; the post-May-12 regime is what matters for forward sentiment pressure.
Verify before trusting this (5)
- Any Q2 2026 pre-announcement or guidance update - a clean print would begin to erase the May scar
- Progress or dismissal of the lawsuits cited in the May 12 news
- Sell-side revisions post-Q1 - a stabilization in estimates would signal the sentiment bleed is done
- Whether VIX stays sub-18 and small-cap industrials catch a bid; a risk-on rotation would disproportionately help beta-2 names
- Any customer-win or emission-regulation headline that could reignite the fuel-agnostic-engine story
This lens hasn't been run for this ticker yet.